Experience with Luspatercept in SF3B1-mutant Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders marked by ineffective hematopoiesis and cytopenias. SF3B1-mutated MDS, now classified as MDS with low blasts and SF3B1 mutation (MDS-SF3B1) in the 2025 World Health Organization update, represents a distinct...
Sparad:
| Huvudupphov: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| Serie: | Archives of Medicine and Health Sciences |
| Ämnen: | |
| Länkar: | https://journals.lww.com/10.4103/amhs.amhs_315_25 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|